The Current Ratio as of November 2024 (TTM) for Tango Therapeutics, Inc. (TNGX) is 7.49

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.49. This represents a change of -5.83% compared to the average of 7.95 of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical Current Ratio (quarterly & annually)

How has TNGX Current Ratio performed in the past?

The mean historical Current Ratio of Tango Therapeutics, Inc. over the last ten years is 6.55. The current 7.49 Current Ratio has changed 11.33% with respect to the historical average. Over the past ten years (40 quarters), TNGX's Current Ratio was at its highest in in the September 2020 quarter at 14.10. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Tango Therapeutics, Inc. (TNGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tango Therapeutics, Inc. (TNGX) Average Current Ratio

How has TNGX Current Ratio performed in the past?

The current Current Ratio of Tango Therapeutics, Inc. (TNGX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tango Therapeutics, Inc. (TNGX) Current Ratio vs. Peers

How is TNGX’s Current Ratio compared to its peers?

Tango Therapeutics, Inc.’s Current Ratio is less than Third Harmonic Bio, Inc. (41.13), less than Cullinan Oncology, Inc. (28.87), less than Edgewise Therapeutics, Inc. (30.24), less than Rallybio Corporation (7.52), greater than Monte Rosa Therapeutics, Inc. (6.56), less than Connect Biopharma Holdings Limited (12.04), less than Tyra Biosciences, Inc. (36.46), less than RAPT Therapeutics, Inc. (8.14), greater than Xilio Therapeutics, Inc. (2.02), less than Mineralys Therapeutics, Inc. (11.20), greater than Foghorn Therapeutics Inc. (5.69), less than Shattuck Labs, Inc. (7.62), less than Kymera Therapeutics, Inc. (8.55), greater than Nurix Therapeutics, Inc. (5.28), greater than TCR2 Therapeutics Inc. (2.96), less than Revolution Medicines, Inc. (15.42), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Atreca, Inc. (1.58), less than Passage Bio, Inc. (7.67), less than Relay Therapeutics, Inc. (15.64), greater than Stoke Therapeutics, Inc. (6.67), less than Pliant Therapeutics, Inc. (14.47), greater than Arvinas, Inc. (4.17),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.